NCT02825563View on ClinicalTrials.gov

A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

August 15, 2018

Study Completion Date

August 15, 2018

Conditions
Advanced Cancer
Interventions
DRUG

Anlotinib

in the fasting state

DRUG

Anlotinib

in the high fat diet

Trial Locations (1)

510060

Sun Yat-sen University Cancer Center, Guangzhou

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY